Opportunities for Deep Tech Startups Amid Covid-19 Pandemic

Summary

East Ventures, a venture capital company that actively invests in Indonesian startups, launched a program called Indonesia Pasti Bisa to develop and produce 100 thousand test kits for Covid-19. East Ventures runs the program through Nusantics, a genomics technology company in its investment portfolio. Nusantics implements advanced genomic research for consumer products and will produce 100 test kit prototypes before producing 100 thousand test kits.

In a press release, Nusantics said it would run a genome sequencing on the new coronavirus. This step is vital because Covid-19 continues to mutate to adapt to the host and its environment. Therefore, this phase is needed in the research and development of antivirus for Covid-19 in Indonesia.

Register now and get free access.

If you want to get free access to our Daily Insights and Weekly Digest, please click "Sign up" button below. If you already have an account, please login.

What do subscribers receive?

As a subscriber, you'll receive daily insights, weekly business digests, and quarterly industrial reports.

What kind of pieces will i get?

In-depth reports on assumption and impact analysis, as well as update and trends mapping, written by our credible and experienced analysts.

And, there is something else…

Register now and get free access, click here to register. Feel free to contact us with any additional questions you have.